2m 2m 2m 2m 2m 2m 2m
ELOXX PHARMACT (ELOX)
NASDAQ
$17.83-$0.62 (-3.39%)
Price as of Aug 04, 2026 8:09 AM EDT- $63.4MMarket Cap
- 1,677,172.73%1-Year Change
- BiotechnologyIndustry
ELOXX PHARMACT (ELOX)
$17.83-$0.62 (-3.39%)
ELOX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.45 | ||
Change | +$1.02 (+5.85%) | ||
Open | $18.24 | ||
High | $19.36 | ||
Low | $15.67 | ||
Previous Close | $17.43 | ||
Volume | 65,837 | ||
30-Day Average Volume | 67,785 | ||
1-Week Change | 52.35% | ||
1-Month Change | 46.84% | ||
1-Year Change | 1,677,172.73% | ||
3-Year Change | -74.20% | ||
5-Year Change | -96.92% | ||
Fundamentals | |||
Shares Outstanding | 3.4M | ||
Total Assets | $8.5M | ||
Market Cap | $63.4M | ||
Enterprise Value | $57.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$3.8M | ||
Free Cash Flow | -$5.5M | ||
EBIT | -$3.7M | ||
EBITDA | -$3.7M | ||
Net Working Capital | N/A | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -8 | ||
P/E | -231 | ||
PEG | -2 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue